These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37001174)

  • 1. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain.
    Docampo-Simón A; Sánchez-Pujol MJ; Pastor-Nieto MA; Giménez-Arnau A; Rodríguez-Serna M; Serra-Baldrich E; Miquel J; Sánchez-Pérez J; Sanz-Sánchez T; Zaragoza-Ninet V; Sánchez-Pedreño P; Carrascosa JM; Gatica-Ortega ME; Fernández-Redondo V; Córdoba-Guijarro S; González-Pérez R; Silvestre JF
    Dermatitis; 2023; 34(4):315-322. PubMed ID: 37001174
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.
    Stout M; Silverberg JI
    J Am Acad Dermatol; 2019 Jul; 81(1):157-162. PubMed ID: 30885752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion.
    Chen JK; Jacob SE; Nedorost ST; Hanifin JM; Simpson EL; Boguniewicz M; Watsky KL; Lugo-Somolinos A; Hamann CR; Eberting CL; Silverberg JI; Thyssen JP
    Dermatitis; 2016; 27(4):186-92. PubMed ID: 27427820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016.
    Silverberg JI; Hou A; Warshaw EM; DeKoven JG; Maibach HI; Belsito DV; Taylor JS; Zug KA; Sasseville D; Fransway AF; DeLeo VA; Pratt MD; Reeder MJ; Fowler JF; Zirwas MJ; Marks JG; Atwater AR
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2853-2866.e14. PubMed ID: 33781959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing.
    Johnson H; Adler BL; Yu J
    Cutis; 2022 May; 109(5):265-267. PubMed ID: 35856769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and genetic variation in atopic dermatitis patients with and without allergic contact dermatitis.
    Lee S; Wang HY; Kim E; Hwang HJ; Choi E; Lee H; Choi EH
    Eur J Dermatol; 2018 Oct; 28(5):637-643. PubMed ID: 30530433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).
    Mora-Fernández V; Mercader Garcia P; Borrego Hernando L; González Pérez R; Córdoba Guijarro S; Giménez Arnau A; Ruiz González I; Miquel Miquel FJ; Silvestre Salvador JF; Ortiz de Frutos FJ; Sanz Sanchez T; Rodríguez Serna M; Fernández Redondo V; Sanchez Perez J; Heras Mendaza F; Serra Baldrich E; Zaragoza Ninet V; Pastor Nieto MA; Hervella Garcia M; Garcia Doval I; Carrascosa JM
    Actas Dermosifiliogr; 2022 Mar; 113(3):236-243. PubMed ID: 35526918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing.
    Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE
    Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.
    Malajian D; Belsito DV
    J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch tests and hand eczema: retrospective study in 173 patients and literature review.
    Suzuki NM; Hafner MFS; Lazzarini R; Duarte IAG; Veasey JV
    An Bras Dermatol; 2023; 98(3):339-346. PubMed ID: 36870887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized.
    Boonstra M; Rustemeyer T; Middelkamp-Hup MA
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1554-1561. PubMed ID: 29578626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
    Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
    Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental contact factors in eczema and the results of patch testing Chinese patients with a modified European standard series of allergens.
    Li LF; Guo J; Wang J
    Contact Dermatitis; 2004 Jul; 51(1):22-5. PubMed ID: 15291828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives.
    Shaughnessy CN; Malajian D; Belsito DV
    J Am Acad Dermatol; 2014 Jan; 70(1):102-7. PubMed ID: 24220722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
    Wollenberg A; Beck LA; Blauvelt A; Simpson EL; Chen Z; Chen Q; Shumel B; Khokhar FA; Hultsch T; Rizova E; Rossi AB; Graham NMH; Pirozzi G; Lu Y; Ardeleanu M
    Br J Dermatol; 2020 Jun; 182(6):e186-e209. PubMed ID: 32476149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopy Associated With Positive Patch Test and Possible Allergic Contact Dermatitis.
    Kirchhof MG; de Gannes GC
    J Cutan Med Surg; 2018; 22(4):405-410. PubMed ID: 29457485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis in patients with atopic dermatitis: A clinical study.
    Sharma AD
    Indian J Dermatol Venereol Leprol; 2005; 71(2):96-8. PubMed ID: 16394381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.